Release Date: October 31, 2025
Expiration Date: October 31, 2026
Activity Overview
This online, on-demand virtual symposium brings together renowned experts in neuromuscular disease, with a focus on generalized myasthenia gravis (gMG). In this educational program, these experts discuss the groundbreaking therapies now available that target the underlying autoimmune mechanisms more precisely than traditional treatments. These targeted therapies represent a shift from broad immunosuppression to more precise interventions, offering patients better symptom control with potentially fewer adverse effects compared to traditional corticosteroids and immunosuppressants.
This educational activity is an archive of the live symposium held on September 27, 2025.
Target Audience
This educational activity is directed toward neuromuscular disease specialists, neurologists, specialty nurse practitioners, specialty physician assistants, nurses, and other health care providers involved in the care of patients with neuromuscular diseases.
Learning Objectives
Upon successful completion of this activity, you should be better prepared to:
- Identify the pathophysiological pathways underlying generalized myasthenia gravis
- Evaluate emerging data on targeted therapies for gMG
- Integrate targeted therapies into individualized management plans for patients with gMG
James F. Howard Jr, MD, FAAN
Professor of Neurology, Medicine, and Allied Health
Director, Myasthenia Gravis Clinical Trials and Translational
Research
Program
UNC School of Medicine
The University of North Carolina at Chapel Hill
Chapel Hill, NC
Disclosures: Honoraria: Alexion Pharmaceuticals, Argenx, Biologix Pharma; Research Support to Institution: Alexion Pharmaceuticals, Argenx, Biologix Pharma, Millennium Pharmaceuticals
Faculty, Staff, and Planners’ Disclosures
The staff of Physicians’ Education Resource®, LLC, have no relevant financial relationships with ineligible companies.
PER® mitigated all COI for faculty, staff, and planners prior to the start of this activity by using a multistep process.
Off-Label Disclosure and Disclaimer
This activity may or may not discuss investigational, unapproved, or off-label use of drugs. Learners are advised to consult prescribing information for any products discussed. The information provided in this accredited activity is for continuing education purposes only and is not meant to substitute for the independent clinical judgment of a health care professional relative to diagnostic, treatment, or management options for a specific patient’s medical condition. The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER® or any company that provided commercial support for this activity.
GET STARTED WITH THIS PROGRAM:
Register now to gain access to this program.
Create AccountAlready Registered? Login Here